Current Status and Future Prospects for Esophageal Cancer
Cancers · 26.01.2023 · 15 (3) · 765
DOI: 10.3390/cancers15030765 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.01.2023. Verfasst von Mahdi Sheikh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), 69007 Lyon, France. Die Arbeit wurde bisher 271-mal zitiert (Crossref) und nennt 295 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.
Abstract (Originalsprache)
Esophageal cancer (EC) is the ninth most common cancer and the sixth leading cause of cancer deaths worldwide. Esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) are the two main histological subtypes with distinct epidemiological and clinical features. While the global incidence of ESCC is declining, the incidence of EAC is increasing in many countries. Decades of epidemiologic research have identified distinct environmental exposures for ESCC and EAC subtypes. Recent advances in understanding the genomic aspects of EC have advanced our understanding of EC causes and led to using specific genomic alterations in EC tumors as biomarkers for early diagnosis, treatment, and prognosis of this cancer. Nevertheless, the prognosis of EC is still poor, with a five-year survival rate of less than 20%. Currently, there are significant challenges for early detection and secondary prevention for both ESCC and EAC subtypes, but Cytosponge™ is shifting this position for EAC. Primary prevention remains the preferred strategy for reducing the global burden of EC. In this review, we will summarize recent advances, current status, and future prospects of the studies related to epidemiology, time trends, environmental risk factors, prevention, early diagnosis, and treatment for both EC subtypes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), 69007 Lyon, France.
- Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan 49341-74515, Iran.
- Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), 69007 Lyon, France.
- Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran 14117-13135, Iran.
ORCID-Profile: Mahdi Sheikh
Förderung
- World Health Organization
Zitieren
APA
Sheikh, M., Roshandel, G., McCormack, V., & Malekzadeh, R. (2023). Current Status and Future Prospects for Esophageal Cancer. Cancers, 15(3), 765. https://doi.org/10.3390/cancers15030765
Vancouver
Sheikh M, Roshandel G, McCormack V, Malekzadeh R. Current Status and Future Prospects for Esophageal Cancer. Cancers. 2023;15(3):765. doi:10.3390/cancers15030765
BibTeX
@article{Sheikh2023,
author = {Sheikh, Mahdi and Roshandel, Gholamreza and McCormack, Valerie and Malekzadeh, Reza},
title = {Current Status and Future Prospects for Esophageal Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {765},
doi = {10.3390/cancers15030765}
}
EUVIMED